Psychiatry/Behavioral · PANCE / PANRE

Acute Psychosis Evaluation

Systematic workup of new-onset or acute exacerbation of psychotic symptoms to identify medical, substance, and primary psychiatric causes.

Also known as: acute psychosis, first-episode psychosis, new-onset psychosis

Overview

Acute onset or exacerbation of psychotic symptoms — delusions, hallucinations, disorganized thought, grossly disorganized/catatonic behavior, or negative symptoms — requiring urgent evaluation to distinguish primary psychiatric, substance-induced, and medical/neurologic etiologies, and to initiate safe and effective management.

Epidemiology

First-episode psychosis incidence ~15-30 per 100,000/year. Peak onset late teens through 30s; men present 3-5 years earlier than women. Acute exacerbations common in established schizophrenia, schizoaffective disorder, bipolar I, and severe MDD.

Try two board-style Acute Psychosis Evaluation questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1PsychiatryMedium
A 19-year-old man has 2 months of social withdrawal, declining grades, talking to himself, laughing inappropriately, and believing his roommate is an FBI agent. Urine toxicology is negative. Which of the following is the most appropriate initial pharmacotherapy?
  • AClozapine
  • BSertraline
  • CLithium
  • DLorazepam
  • ERisperidone
Reveal answer & full explanation
Correct answer: E — Risperidone
  • AClozapine
  • BSertraline
  • CLithium
  • DLorazepam
  • ERisperidone✓

Why risperidone is correct

  • This patient presents with first-episode psychosis: 2 months of positive symptoms including delusions (believing roommate is an FBI agent), hallucinations (talking to himself), and disorganized behavior (laughing inappropriately)
  • Initial pharmacotherapy for first-episode psychosis is a second-generation antipsychotic such as risperidone or aripiprazole
  • Coordinated specialty care combining medication, psychotherapy, family psychoeducation, and supported education is most effective
  • Duration of untreated psychosis correlates with worse outcomes

Why the others are wrong

  • Sertraline — a selective serotonin reuptake inhibitor; treats depression/anxiety, not psychosis
  • Lithium — a mood stabilizer used in bipolar disorder; not indicated for first-episode psychosis without a clear mood component
  • Lorazepam — a benzodiazepine; may provide short-term agitation control but is not a primary antipsychotic treatment
  • Clozapine — the most effective antipsychotic for schizophrenia, but reserved for treatment-resistant illness after adequate trials of two other antipsychotics or for persistent suicidality because of its risks of severe neutropenia, seizures, myocarditis, and metabolic effects; it is not initial therapy for first-episode psychosis
Question 2PsychiatryMedium
A 25-year-old male has a first episode of psychosis with auditory hallucinations, paranoid delusions, disorganized speech, and flat affect for 3 months. He uses cannabis. Brain MRI and labs are normal. He is started on risperidone. Which of the following pharmacologic strategies is most likely to reduce his risk of psychotic relapse?
  • AIntermittent antipsychotic dosing
  • BLong-acting injectable antipsychotic
  • CTwo concurrent oral antipsychotics
  • DContinued oral antipsychotic
  • EGuided antipsychotic dose reduction
Reveal answer & full explanation
Correct answer: B — Long-acting injectable antipsychotic
  • AIntermittent antipsychotic dosing
  • BLong-acting injectable antipsychotic✓
  • CTwo concurrent oral antipsychotics
  • DContinued oral antipsychotic
  • EGuided antipsychotic dose reduction

Why Long-acting injectable antipsychotic is correct

  • Medication non-adherence is the biggest driver of relapse in first-episode psychosis (FEP) — over 50% relapse within 5 years
  • Long-acting injectable (LAI) antipsychotics (aripiprazole lauroxil, paliperidone palmitate, risperidone microspheres) lower relapse and hospitalization compared with oral antipsychotics across randomized trials (pooled risk ratio about 0.88), with larger effects in mirror-image and real-world studies
  • After a first episode of schizophrenia, a randomized trial found far fewer relapses with LAI risperidone than with oral risperidone over 12 months (5% vs 33%; Subotnik 2015)

Why the others are wrong

  • Continued oral antipsychotic — continuous oral maintenance clearly lowers relapse compared with placebo or discontinuation, but partial or covert nonadherence is common after a first episode, especially with ongoing cannabis use, and LAIs lower relapse further than oral dosing in randomized trials
  • Two concurrent oral antipsychotics — antipsychotic polypharmacy is not recommended; does not improve outcomes and increases side effects
  • Intermittent antipsychotic dosing — randomized trials of prodrome-triggered intermittent treatment show higher relapse and rehospitalization rates than continuous maintenance therapy
  • Guided antipsychotic dose reduction — tempting because long-term follow-up of a first-episode trial linked early dose reduction with better functional recovery, but randomized trials of tapering or discontinuing antipsychotics after a first episode show more relapses than continuous maintenance treatment, so it raises rather than lowers his relapse risk

Additional high-yield points

  • Coordinated specialty care for FEP improves employment, school functioning, and symptoms, and reduces hospitalization
  • Treatment duration: minimum 1-2 years after first episode, often lifelong

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Psychosis Evaluation outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Family history of psychotic illness
  • Substance use — cannabis (high-potency THC), methamphetamine, cocaine, hallucinogens, synthetic cannabinoids
  • Medications — corticosteroids, anticholinergics, dopaminergic agents, levodopa, sympathomimetics
  • Medical/neurologic conditions — delirium, encephalitis, stroke, seizure (post-ictal), CNS infection, autoimmune (anti-NMDA), metabolic (hypoglycemia, hyponatremia, hypercalcemia, B12 deficiency, hepatic/uremic encephalopathy), endocrine (hyper/hypothyroidism, Cushing)
  • Sleep deprivation, postpartum (postpartum psychosis is a psychiatric emergency)

Pathophysiology

Final common pathway involves dysregulated mesolimbic dopaminergic signaling, with contributions from glutamatergic, GABAergic, serotonergic, and cholinergic systems depending on etiology. Inflammatory and structural mechanisms in delirium and autoimmune encephalitis.

Clinical presentation

Symptoms

  • Hallucinations (auditory most common in primary psychiatric; visual, tactile, olfactory raise concern for medical/substance etiology)
  • Delusions — persecutory, referential, grandiose, somatic, bizarre
  • Disorganized speech and behavior
  • Negative symptoms — flat affect, alogia, avolition
  • Catatonia — stupor, mutism, posturing, waxy flexibility, echolalia/echopraxia
  • Associated: agitation, suicidality, command hallucinations, sleep loss

Signs / physical exam

  • Vital signs — fever, HTN, tachycardia raise concern for medical cause
  • Neurologic exam — focal deficits, abnormal movements, papilledema
  • Pupils — pinpoint (opioids), mydriasis (sympathomimetics, anticholinergics)
  • Skin — needle marks, rashes, anticholinergic flushing
  • Mental status — orientation, attention (serial 7s, months backward; asterixis suggests metabolic encephalopathy) — inattention/clouded sensorium points to delirium

Differential diagnosis

  • Delirium — Acute onset, fluctuating course, inattention, altered consciousness — search for underlying medical cause
  • Substance-induced psychosis — Temporal relationship to use or withdrawal (stimulants, cannabis, hallucinogens, alcohol withdrawal); resolves with abstinence
  • Primary psychotic disorder — Schizophrenia, schizophreniform, schizoaffective, brief psychotic, delusional — by duration and pattern
  • Mood disorder with psychotic features — Mood congruent or incongruent psychosis confined to MDE or manic episode
  • Anti-NMDA receptor encephalitis — Subacute behavioral change, autonomic instability, seizures, dyskinesias; often ovarian teratoma — LP, autoimmune panel
  • CNS infection — Encephalitis, meningitis, neurosyphilis, HIV — fever, meningismus, focal signs
  • Seizure-related — Post-ictal psychosis, complex partial seizures, NCSE
  • Endocrine/metabolic — Thyroid storm, Cushing, B12, hypercalcemia, hyponatremia
  • Postpartum psychosis — Onset usually within the first 2 weeks postpartum; rapid mood/cognition shifts; strongest risk factors are personal or family history of bipolar disorder and prior postpartum psychosis; PSYCHIATRIC EMERGENCY due to suicide and infanticide risk

Diagnostic workup

Diagnostic criteria

Workup-driven differential. Delirium per DSM-5-TR requires disturbance in attention and awareness developing over hours to days with fluctuation and evidence of an underlying medical cause. Primary psychotic disorders categorized by duration and mood context (see Schizophrenia entry).

Labs

  • CBC, CMP (Ca, glucose), Mg, phosphate, LFTs
  • TSH, B12, folate; thiamine if malnourished
  • Urinalysis, urine drug screen (including fentanyl, synthetic cannabinoids if available)
  • Blood alcohol
  • Pregnancy test in women of reproductive age
  • Syphilis serology, HIV; consider hepatitis panel
  • ESR/CRP; ANA if autoimmune concern
  • Acetaminophen and salicylate levels if overdose possible
  • ECG (QTc baseline before antipsychotic, and especially for haloperidol, ziprasidone, IV antipsychotics)
  • Ammonia, ABG, lactate if metabolic encephalopathy suspected
  • LP if febrile, meningismus, immunocompromised, or autoimmune encephalitis suspected

Imaging

  • Non-contrast head CT in first-episode psychosis, focal neurologic findings, trauma, altered consciousness
  • MRI brain when feasible — higher sensitivity for demyelination, autoimmune encephalitis, structural lesions
  • EEG if seizure suspected or to evaluate encephalopathy / non-convulsive status epilepticus

Diagnostic algorithm

flowchart TD
  A[Acute psychotic presentation] --> B[Stabilize and ensure safety<br/>vital signs, focused exam]
  B --> C{Vital sign or<br/>neurologic abnormality?}
  C -->|Yes| D[Workup for medical cause<br/>labs, head imaging, +/- LP/EEG]
  C -->|No| L{"First episode, age >50,<br/>or atypical features?"}
  L -->|Yes| M["Baseline medical workup<br/>CBC, CMP, TSH, B12, RPR, HIV,<br/>pregnancy test +/- neuroimaging"]
  L -->|No| E[Targeted psychiatric +<br/>substance workup]
  M -->|Cause found| G
  M -->|Unrevealing| E
  D --> F{Delirium / medical /<br/>autoimmune / infectious?}
  F -->|Yes| G[Treat underlying cause<br/>+ supportive care]
  F -->|No| H[Likely primary psychiatric]
  E --> I{Substance present?}
  I -->|Yes| J[Substance-induced<br/>reassess after abstinence]
  I -->|No| H
  H --> K[Antipsychotic +<br/>coordinated specialty care]
Acute psychosis triage from presentation to disposition.

Treatment

First-line

  • Stabilize ABC; protect patient and staff; ensure safe environment
  • Verbal de-escalation; offer oral medication before IM
  • Acute agitation: PO/IM olanzapine, risperidone, haloperidol (often + lorazepam) — avoid combining IM olanzapine + IM benzodiazepine due to respiratory depression risk
  • Treat underlying cause — correct hypoglycemia, electrolytes, infection; benzodiazepines for alcohol withdrawal; physostigmine for severe anticholinergic toxicity in select cases; immunotherapy for autoimmune encephalitis
  • Antipsychotic for primary psychotic disorder once medical causes addressed — risperidone, olanzapine, aripiprazole, quetiapine
  • Admit involuntarily if necessary to protect from self-harm or harm to others
  • Reduce stimulation; address sleep; involve family for collateral and supports

Suspected delirium

  • Identify and treat medical cause
  • Reorientation, environmental measures, treat pain, normalize sleep-wake cycle
  • Low-dose antipsychotic for severe agitation/safety; avoid in alcohol/benzo withdrawal (use benzodiazepines)
  • Avoid benzodiazepines as routine delirium treatment (worsens delirium except in withdrawal states)

First-episode primary psychosis

  • Coordinated specialty care — case management, family education, supported employment
  • Antipsychotic with favorable metabolic and EPS profile; shared decision-making
  • Address substance use, particularly cannabis
  • Engage family early; provide long-term follow-up

Postpartum psychosis

  • Psychiatric emergency — inpatient admission with mother-infant safety planning
  • Antipsychotic, mood stabilizer (often lithium), benzodiazepine for agitation; ECT highly effective and rapid
  • Address breastfeeding considerations and infant safety

Second-line / adjunct

  • ECT for refractory or catatonic presentations, severe MDD with psychosis, postpartum psychosis
  • Long-acting injectable antipsychotics — lower relapse and rehospitalization than oral maintenance; offer if adherence is poor or uncertain or the patient prefers them (APA 2020), including early in first-episode psychosis
  • Clozapine for treatment-resistant primary psychotic disorder
  • Address ongoing substance use with MOUD/AUD treatment as appropriate

Complications

  • Self-harm or harm to others during acute phase
  • Neuroleptic malignant syndrome from antipsychotic — discontinue, supportive care, consider dantrolene/bromocriptine
  • QT prolongation, especially with IV haloperidol, ziprasidone, or polypharmacy
  • Catatonia complications: DVT, pressure injuries, malnutrition, aspiration
  • Diagnostic anchoring — missed autoimmune encephalitis, NCSE, intracranial pathology
  • Iatrogenic worsening of delirium with benzodiazepines or anticholinergics

PANCE pearls

  • First-episode psychosis warrants thorough medical workup, including neuroimaging — do not assume primary psychiatric etiology.
  • Visual or tactile hallucinations, fluctuating attention, abnormal vitals, focal neuro findings, or age >50 with new psychosis should escalate medical workup.
  • Anti-NMDA receptor encephalitis classically affects young women (often with ovarian teratoma) — subacute behavioral change, seizures, dyskinesias, autonomic instability; LP shows CSF antibodies.
  • Postpartum psychosis is a psychiatric emergency — distinguish from postpartum depression and 'baby blues'; rapid cycling, suicidality, infanticidal thoughts require admission.
  • Do not use lorazepam IM with IM olanzapine (respiratory and cardiopulmonary depression risk); separate by >=1 hour.
  • In delirium, antipsychotics are for safety only — they do not shorten delirium duration.

References

  • APA 2020 — American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia, 3rd ed. (2020)
  • Freudenreich 2009 — Freudenreich O, Schulz SC, Goff DC. Initial medical work-up of first-episode psychosis: a conceptual review. Early Interv Psychiatry 2009;3(1):10-18
  • Graus 2016 — Graus F et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016
  • ACEP 2017 — American College of Emergency Physicians. Clinical Policy: Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department. Ann Emerg Med 2017;69(4):480-498
  • DSM-5-TR — American Psychiatric Association. DSM-5-TR (2022)

Practice Psychiatry/Behavioral questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.